Therapeutic Advances in Infectious Disease, Volume 13, January-December 2026.
Peptide-based vaccines, utilizing defined B- and T-cell epitopes, have emerged over the past two decades as promising alternatives to conventional vaccine platforms. Their key advantages, including excellent safety profiles, precise immunological ...